LCTU Post-Trial Tissue Bank
|Funding||Funded via cost-recovery.|
|Status||Funding awarded/in set-up|
Established in 1996, the Liverpool Clinical Trials Unit (LCTU) has managed a broad portfolio of clinical trials with particular emphasis on hepato-pancreato-biliary, uveal, breast, head and neck, haematological and urothelial malignancies. The LCTU is supported in the delivery of translational activity of clinical trials by the Liverpool Good Clinical Practice (GCP) laboratories. Following completion of clinical trials managed by the LCTU, samples have previously been stored under several established tissue banks with separate ethical approval and governance structures. The LCTU Post-Trial Tissue Bank merges all translational samples into a global tissue bank which has a single overarching access and application policy. The collection consists of samples and data collected from individuals who have participated in clinical trials managed by the LCTU and who have given informed consent for the use of their samples in translational research activity. The samples and data available fall under five core malignancy groups: Hepato-pancreato-biliary cancers, uveal melanoma, head and neck cancers, breast cancer and lung cancer. The LCTU Post-Trial Tissue Bank collection offers an invaluable resource of high quality biological samples and associated data for researchers and ensures samples provided by donors are used to their full potential in high quality clinical research.